TEL belongs to a member of the ETS family transcription factors that represses transcription of target genes such as FLI-1. Although TEL is essential for establishing hematopoiesis in neonatal bone marrow, its role in erythroid lineage is not understood. To investigate a role for TEL in erythroid differentiation, we introduced TEL into mouse erythroleukemia (MEL) cells. Overexpressing wild-type-TEL in MEL cells enhanced differentiation induced by hexamethylene bisacetamide or dimethylsulfoxide, as judged by the increased levels of erythroidspecific d-aminolevulinate synthase and b-globin mRNAs. TEL bound to a corepressor mSin3A through the helixloop-helix domain. A TEL mutant lacking this domain still bound to the ETS binding site, but lost its transrepressional effect. This mutant completely blocked erythroid differentiation in MEL cells. Moreover, it showed dominant-negative effects over TEL-mediated transcriptional repression and acceleration of erythroid differentiation. Endogenous TEL mRNA was found to increase during the first 3 days in differentiating MEL cells and drastically decrease thereafter. All these data suggest that TEL might play some role in erythroid cell differentiation.
Introduction
TEL is a member of the ETS family transcription factors (Golub et al., 1994) that acts as a transcriptional repressor Lopez et al., 1999) . It contains two functional domains: the helix-loop-helix (HLH) domain (also called the pointed domain) at the N-terminus and the ETS domain at the C-terminus. The HLH domain is necessary for homodimerization (Kim et al., 2001) and heterodimerization with other ETS family members such as FLI-1 Kwiatkowski et al., 1998) or TEL2 Gu et al., 2001) . The ETS domain is responsible for DNA binding to the ETS-binding consensus site (EBS) that contains a purine-rich GGAA/T core motif. Being a transcriptional repressor, TEL is known to interact with some relevant cofactors. TEL associates with mSin3A and N-CoR through the HLH and central repression domains (amino acids 268-303), respectively (Wang and Hiebert, 2001) . Moreover, TEL directly binds to histone deacetylase (HDAC)-3 through the internal domain. By interacting with HDAC-3, TEL is believed to mediate transcriptional repression of target genes such as FLI-1 (Lopez et al., 1999) , Idl (Martinez and Golub, 2000) , and stromelysin-1 (Fenrick et al., 2000) . TEL is a nuclear phosphoprotein that possesses multiple putative MAPK phosphorylation sites . However, functional significance of the phosphorylation has not been elucidated.
The TEL gene, mapped at 12pl3, was originally identified as a fusion partner for the platelet-derived growth factor receptor b(PDGFRb) gene in the t(5;12)(q33;p13) translocation found in chronic myelomonocytic leukemia (Golub et al., 1994) . Since then, various 12pl3 translocations, involving the TEL gene and thus generating the TEL-related chimeric genes, have been discovered in many types of hematological malignancies. In some translocations, receptor-type or nonreceptor-type tyrosine kinases are fused to the N-terminal portion of TEL, and thus activated by homodimerizing through the HLH domain in the TEL moiety. Examples include PDGFRb in t(5;12)(q33;p13) (Jousset et al., 1997) , ABL in t(9;12)(q34;p13) , JAK2 in t(9:12)(p24;p13) (Lacronique et al., 1997) , and Syk in t(9;12)(q22;p13) (Kuno et al., 2001) . In other cases, transcription factors are functionally modified by fusing with the N-or C-terminal part of TEL. Examples are shown in AML1 in t(12;21)(p13;q22) (Hiebert et al., 1996; Fenrick et al., 1999; Guidez et al., 2000) and MN1 in t(12;22)(p13;qll) . Thus, perturbing original functions of the partner genes could be a mechanism of causing leukemia in patients with such translocations. The tumor-suppressive function of TEL is also suggested, because expression of TEL in Ras-transformed NIH3T3 cells inhibits cell growth in liquid and soft agar cultures, and suppresses tumor formation in nude mice (Fenrick et al., 2000; van Rompaey et al., 2000) .
TEL is widely expressed in embryonic and adult tissues. TEL knockout mice die between E10.5-11.5 with defective yolk sac angiogenesis and intra-embryonic apoptosis of mesenchymal and neural cells, although hematopoiesis in the yolk sac is unaffected (Wang et al., 1997) . As a result of the embryonic lethality, roles of TEL in fetal liver and after-birth bone marrow hematopoiesis are not fully understood. However, the analysis of chimeric mice with TEL(À/À) ES cells showed that TEL is dispensable for the intrinsic proliferation and differentiation of adult-type hematopoiesis in the yolk sac and fetal liver, but is essential for the establishment of after-birth hematopoiesis for all lineages in the bone marrow (Wang et al., 1998) .
FLI-1 is a transcription factor that is demonstrated to inhibit erythroid differentiation (Pereira et al., 1999; Starck et al., 1999; Athanasiou et al., 2000) .
Since TEL is reported to repress the FLI-1 promoter (Lopez et al., 1999) and block FLI-l's function (Kwiatkowski et al., 1998) , it is probable that TEL plays a role in the differentiation of erythroid progenitors through regulating FLI-1. To investigate this possibility in vivo, we introduced TEL into Friend virus-induced mouse erythroleukemia (MEL) cells. The MEL cells expressing wild-type-TEL showed an accelerated erythroid differentiation after treatment with hexamethylene bisacetamide (HMBA) or dimethylsulfoxide (DMSO). TEL associated with mSin3A through the HLH domain. Removal of this domain abrogated TEL's suppressive function on the EBS promoter. Importantly, when this mutant was introduced into MEL cells, it completely blocked the erythroid differentiation. These findings reveal that the transcriptionally suppressive function of TEL mediated by the HLH domain might regulate erythroid cell differentiation.
Results
Overexpression of wild-type-TEL stimulates erythroid differentiation in MEL cells upon HMBA or DMSO treatment First, we investigated whether TEL plays any role in erythroid cell proliferation and differentiation. We established several MEL (Friend et al., 1971; Marks and Rifkind, 1978) stable cell lines expressing wild-type-TEL by transfecting FLAG-tagged TEL expression plasmid (pCXN2-FLAG-TEL) and selecting cells by G418 resistance. The Western analysis with anti-FLAG antibody revealed that T-14 and T-15 were representative clones expressing high levels of wild-type-TEL ( Figure 1a ). Two MEL clones, which were transfected with the vector plasmid, were used as controls (M-l and M-2). All four clones described above showed comparable viability and proliferation with one another (data not shown). The MEL cell is induced into terminal erythroid differentiation by treatment with HMBA or DMSO, providing an ideal system to analyze gene functions in erythroid differentiation. To test the effect of overexpressing wild-type-TEL on erythroid differentiation, we treated the clones with HMBA or DMSO. Interestingly, clones T-14 and T-15 reproducibly displayed higher percentages of benzidine-positive cells than the M-l and M-2 controls (Figure 1b,c) . To obtain molecular evidence of the terminal erythroid differentiation observed in these clones, we analyzed the levels of erythroid-specific d-aminolevulinate synthase (ALAS-E) and b-globin transcripts. In M-l, these transcripts were not detected at day 0, but observed weakly at day 2, and maximally at day 3 (Figure 2a ). In contrast, both mRNAs were clearly observed at day 0 in T-14 and T-15. Expressions of the two transcripts at day 2 were much stronger in T-14 and T-15 than in M-l. The steady expressions of the transcripts were achieved after 3 days in T-14 and T-15, as in M-l.
These data confirm that overexpressing wild-type-TEL accelerates erythroid differentiation in MEL cells.
Overexpression of wild-type-TEL does not alter the levels of FLI-1
To examine whether TEL accelerates erythroid differentiation in MEL cells by inhibiting the expression of FLI-1, we examined the protein levels of FLI-1 in nuclear extracts during the erythroid differentiation. However, overexpression of wild-type-TEL did not change the amounts of FLI-1 along the differentiation (Figure 2b ).
Wild-type-TEL associates with mSin3A through the HLH domain
Since TEL is a transcriptional repressor, we tested which corepressors interact with TEL. mSin3A Nagy et al., 1997) , SMRT (Nagy et al., 1997) , T7-tagged CtBP (Turner and Crossley, 2001) , or FLAGtagged c-Ski (Nicol and Stavnezer 1998) was coexpressed with FLAG-tagged or HA-tagged TEL in COS7 cells, and the immunoprecipitations were performed using antibodies against mSin3A, SMRT, T7, or FLAG. Wild-type-TEL was coimmunoprecipitated with antimSin3A antibody, but not with the other antibodies (data not shown). This suggests that TEL could recruit HDAC through mSin3A to function as a transcriptional repressor. Next, we constructed a set of deletion mutants lacking the HLH (DHLH), ETS (DETS), and internal (DID) domains, to determine the mSin3A-binding region for TEL (Figure 3a) . Expressions of the mutants in transfected COS7 cells were confirmed by Western analysis (Figure 3b , right). When these mutants were coexpressed with mSin3A and immunoprecipitated with anti-mSin3A antibody, the DID and DETS mutants, but not the DHLH mutant, were detected in the immunoprecipitates (Figure 3b, left) . This indicates that the HLH domain, which is responsible for homodimerization or heterodimerization, is also necessary for mSin3A binding and is thus considered critical for TEL's function as a transcription repressor. To further dissect the role of the HLH domain, we compared molecular functions of wild-type-TEL and DHLH-TEL in DNAbinding and transcriptional reporter assays.
DHLH mutant shows the same DNA-binding affinity as TEL
To analyze whether DHLH-TEL still has the EBSspecific DNA-binding property as wild-type-TEL, cell lysates prepared from mock, or wild-type-TEL-or DHLH-TEL-expressing COS7 cells were subjected to EMSA using radioactive EBS oligonucleotide as a probe . As shown in Figures 4a and b, both wild-type-TEL and DHLH-TEL generated a specific DNA-protein complex that was supershifted with anti-TEL antibody and was not seen in the mock lysate. These bands represented a specific binding of wild-type-TEL or DHLH-TEL to the EBS probe, since the binding was completely canceled by cold specific competitors but not by nonspecific competitors (oligonucleotides A and M). All lysates including mock showed a slowermigrating EBS-specific band (Band ETS). However, this band was not supershifted with anti-TEL antibody and was thus regarded as endogenous EBS-binding activity that pre-exists in the COS7 lysates. From this result, we concluded that wild-type-TEL and DHLH-TEL have comparable DNA-binding ability to the ETSbinding site.
DHLH-TEL is a negative regulator for transcriptional repression by wild-type-TEL
In order to get more insights into the functional alteration of DHLH-TEL, we investigated transcriptional regulatory properties of wild-type-TEL and DHLH-TEL on (ETS) 3 tkLuc. This reporter plasmid contains three tandem repeats of EBS inserted into the 5 0 region of the herpes simplex virus thymidine kinase promoter (À80 to +52), followed by the luciferase gene (Janknecht et al., 1993) . HeLa cells were initially used in this experiment because they have high endogenous activities for EBS-mediated transcription (Lopez et al., 1999) . We transfected (ETS) 3 tkLuc or (mETS) 3 tkLuc (mutated EBS-containing (ETS) 3 tkLuc) along with wild-type-TEL or DHLH-TEL expression plasmid into HeLa cells and evaluated luciferase activities. Cotransfection of (ETS) 3 tkLuc with wild-type-TEL expression plasmid resulted in a dose-dependent decrease of the luciferase activity (Figure 5a ). This repression appears to be EBS mediated since wild-type-TEL did not repress the activity of (mETS) 3 tkLuc. In contrast, no repression was observed when DHLH-TEL or EVI-1 as a control was expressed (Figure 5b,c) . Since DHLH-TEL bound to EBS but showed no transcriptional effects on EBS, we speculated that DHLH-TEL might alter TEL-mediated transcriptional repression. Coexpression of DHLH-TEL abolished the transcriptional suppression by wildtype-TEL in a dose-dependent manner (Figure 5c ). When EVI-1 was coexpressed, the repression by Figure 4 TEL and DHLH bind to EBS. (a) EMSA was carried out using the 32 P-labeled EBS probe (oligonucleotide A) and mock (lanes 1-3), or wild-type-TEL (lanes 4-6) or DHLH-TEL (lanes 7-9) expressing COS7 lysates. A 100-fold molar excess of oligonucleotide A (lanes 2, 5, and 8) or oligonucleotide M (lanes 3, 6, and 9) that contains mutations in the ETS-binding consensus sequence was also added to the reactions. Arrows indicate shifted bands including wild-type-TEL or DHLH-TEL, and endogenous EBS-binding proteins that pre-exist in the COS7 lysates (Band ETS). (b) Anti-TEL antibody (lanes 2, 4, and 6) was also added to the reactions. The supershifted bands are shown with an arrow.
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K Waga et al wild-type-TEL was not affected at all. These data suggest that DHLH-TEL has a dominant-negative effect over the TEL-mediated transcriptional repression.
To evaluate TEL's function in a more biologically relevant condition, we next performed luciferase assays in MEL cells. Wild-type-TEL again repressed the transcription through EBS in dose-and sequencedependent manners (Figure 6a ). DHLH-TEL itself did not exhibit any effects on the EBS promoter (Figure 6b ), but showed a dominant-negative effect on the transcriptional repression by wild-type-TEL (Figure 6c) . Given TEL as a transcriptional repressor, we investigated if 2-8) . In lanes 3-5 or 6-8, 0.05, 0.5, and 0.9 mg of DHLH-TEL or EVI-1 expression plasmid were cotransfected as well. HeLa cells were also transfected with 1 mg of (EBS) 3 tkLuc reporter plasmid along with 0.05, 0.5, and 0.9 mg of EVI-1 expression plasmid alone (lanes 9-11). The results are presented as relative luciferase activities TEL accelerates Friend erythroid diffraction K Waga et al TEL requires HDAC activity to suppress the EBScontaining promoter using an HDAC inhibitor, trichostatin A (TSA). The basal luciferase activity driven by the EBS promoter was unaltered by treatment with TSA at 10 or 25 ng/ml (Figure 6d) . However, the addition of TSA attenuated TEL-mediated transcriptional repression by approximately 90%, indicating that TEL requires HDAC activity to repress the EBS promoter in the erythroid progenitor cells.
DHLH-TEL antagonizes wild-type-TEL-induced erythroid differentiation
Considering that DHLH-TEL has a dominant-negative effect on wild-type-TEL-mediated transcriptional repression in MEL cells, we established DHLH-TELexpressing clones to test the effect of DHLH-TEL on erythroid differentiation. We introduced DHLH-TEL expression plasmid (pCXN2-FLAG-DHLH) into MEL cells and selected cells by G418 resistance. Figure 7a shows the expression of DHLH-TEL in two independent clones (DHLH-6 and DHLH-9). The growth kinetics of these two clones was almost similar to that of the control or wild-type-TEL-expressing clones (data not shown). When stimulated with HMBA or DMSO, the control cells became benzidine positive on day 3 or 4, while the wild-type-TEL-expressing cells showed earlier onset and a higher incidence of benzidine positivity (Figure 7b,c) . Surprisingly, the DHLH-TEL-expressing cells completely lost their abilities to become benzidine positive. Thus, DHLH-TEL completely blocks erythroid differentiation in this model system. Interestingly, overexpressing DHLH-TEL did not change the levels of FLI-1 along the differentiation (Figure 2b) .
It is conceivable that the dominant-negative form of TEL, namely DHLH-TEL, blocks erythroid differentiation by repressing the function of endogenous wild-type-TEL protein. To test this possibility, we further isolated clones that stably express both wild-type-TEL and DHLH-TEL. To this end, we transfected DHLH-TEL expression plasmid (pCAGIPuro-FLAG-DHLH) into the T-14 clone and selected cells by puromycin resistance. We successfully obtained several clones stably expressing both wild-type-TEL and DHLH-TEL (Figure 8a , T-14-D-1 and T-14-D-2). These cells were treated with HMBA and the effect on erythroid differentiation was compared with the control, or wildtype-TEL-or DHLH-TEL-expressing clones (Figure 8b ). The latter three clones underwent the expected kinetics of erythroid differentiation as seen before. Notably, T-14-D-l and T-14-D-2 completely lost the rapid onset and high incidence of the benzidine positivity characteristic to the parental T-14 clone. The differentiation degree was comparable to, or even lower than, the control clones. We concluded that DHLH-TEL could repress the erythroid differentiation in MEL cells by suppressing the propelling function of wild-type-TEL.
Endogenous TEL mRNA transiently increases during erythroid differentiation in MEL cells
If endogenous TEL actually enhances erythroid differentiation, its expression could be upregulated during the course of differentiation. To test this, we semiquantitatively assessed the levels of its mRNA by RT-PCR in two independently repeated experiments, because endogenous TEL mRNA and protein could not be detected by Northern and Western analyses. TEL mRNA was detected in undifferentiated MEL cells, although the level was considerably low (Figure 9 ). When stimulated with HMBA, the mRNA increased up to day 3 and rapidly declined to an undetectable level at day 4. Therefore, intrinsic TEL function may be necessary in the early phases of MEL cell differentiation, probably to alter transcriptions of target genes that are essential for the terminal erythroid differentiation.
Discussion
In this study, we demonstrated that TEL stimulates erythroid differentiation in MEL cells. Given that TEL is a transcriptional repressor, it has been hypothesized that TEL accomplishes its physiological roles by suppressing or modifying gene expression. However, overexpression of wild-type-TEL does not change the levels of FLI-1, a key regulator of erythroid differentiation, in MEL cells. TEL associates with mSin3A through the HLH domain. While DHLH-TEL binds to EBS, it loses the ability to repress transcription through EBS. Therefore, recruitment of mSin3A through the HLH domain could be essential for TEL's suppressive effects. Moreover, DHLH-TEL functions as a dominant-negative molecule of wild-type-TEL, thereby relieving transcriptional repression and preventing erythroid differentiation. All these data suggest that TEL might play a role in erythroid differentiation. The observation that endogenous TEL transcript increases during the early stage of erythroid differentiation also supports our conclusion. The FLI-1 gene is one of the targets of TEL-mediated transcriptional repression (Ben-David et al., 1990 , 1991 Lopez et al., 1999) . The levels of FLI-1 decrease during the course of erythroid differentiation (Starck et al., 1999; Athanasiou et al., 2000) . Forced expression of FLI-1 in avian primary erythroblasts inhibits the terminal differentiation of these cells in response to erythropoietin (Pereira et al., 1999) . FLI-1 is also reported to suppress erythroid differentiation in human K562 cells (Athanasiou et al., 2000) . FLI-1 knockout mice are embryonic lethal by El2.5 because of hemorrhage in the neural tubes and ventricles of the brain, while their livers contain few pronormoblasts and basophilic normoblasts (Spyropoulos et al., 2000) . Therefore, FLI-1 appears to play an important role in erythroid cell survival and proliferation. We investigated the expression levels of FLI-1 in the control, or wildtype-TEL-or DHLH-TEL-expressing MEL cells, and observed that forced expression of wild-type-TEL or DHLH-TEL does not influence the levels of FLI-1. This is probably because the FLI-1 promoter is constitutively stimulated by virally induced PU.l in MEL cells. However, it is plausible that overexpressing wild-type-TEL could repress the molecular functions of FLI-1 in MEL cells, because TEL is reported to exert a dominant-negative effect on FLI-1 in the reporter assays (Kwiatkowski et al., 1998) . Regardless, it is important to note that TEL accelerates erythroid differentiation in MEL cells without lowering the levels of FLI-1. Identification of downstream target genes for TEL, which are important in the stimulation of erythroid differentiation, will provide new insights into hematopoietic regulation in the erythroid lineage.
Recently, a novel ETS gene, designated TEL2, that encodes a protein highly structurally related to TEL has been identified Gu et al., 2001) . TEL2 has several different alternatively spliced transcripts, one of which lacks its HLH domain. Interestingly, using RT-PCR analysis, we also detected an isoform of TEL mRNA lacking the HLH domain that results from the deletion of the sequence encoded by exons 3 and 4 in human mononuclear cells of peripheral blood (unpublished observation). This suggests that two alternatively spliced isoforms of TEL, either with or without the HLH domain, could antagonistically act as a transcriptional regulator. The DHLH-TEL isoform is unable to bind to mSin3A and thus loses the repressive property of wild-type-TEL. Nevertheless, DHLH-TEL retains specific DNA binding for EBS. Therefore, the HLH-lacking isoform may compete with wild-type-TEL for DNA binding to act as a negative regulator of wildtype-TEL. Our study also shows that the two possible isoforms of TEL work in a biologically antagonistic fashion. Wild-type-TEL accelerates erythroid differentiation in MEL cells while DHLH-TEL completely blocks it. Therefore, it is reasonable to speculate that the molecular ratio between the two isoforms could tip the balance of transcription either to halt or promote erythroid differentiation. It will be needed to clarify whether isoforms of TEL really regulate erythroid differentiation in primary cultures or in mice.
Materials and methods

Cell culture
A Friend virus-induced mouse erythroleukemia cell line (MEL-B8) and COS7 cells were maintained in DMEM supplemented with 10% fetal calf serum (FCS). HeLa cells were cultured in MEM supplemented with 10% FCS. To induce erythroid differentiation in MEL cells, 5 mM HMBA (Sigma-Aldrich) or 1.5% DMSO (Wako Chemicals) was added to the culture. Erythroid differentiation was determined by counting the percentage of hemoglobin-producing cells following staining with benzidine. Trichostatin A (SigmaAldrich) was added at 10 or 25 ng/ml to inhibit the activity of histone deacetylases in the culture.
Plasmid construction
Flag (DYKDDDDK) or influenza virus hemagglutinin (HA) tag (YPYDVPDYA) was created upstream from the translation initiation site of wild-type-TEL cDNA by the method of PCR amplification. The resultant cDNAs were inserted into the EcoR1 site of pME18S (Takebe et al., 1988) and pCXN2 plasmids in the sense orientation to give pME18S-FLAG-TEL, pME18S-HA-TEL, and pCXN2-FLAG-TEL, respectively. To construct the deletion mutants, new restriction sites, PmaCI(190) and SmaI(403) for DHLH-TEL, SmaI(403) for DID-TEL, and PstI(1040) and HincII(1282) for DETS-TEL (numbers adopted by Golub et al., 1994) , were created by means of site-directed mutagenesis (Kunkel et al., 1987) in FLAG-tagged wild-type-TEL cDNA cloned into the pBluescript SK plasmid (Stratagene). FLAG-tagged DHLH-TEL and DID-TEL cDNAs were generated by deleting internal fragments from mutagenic PmaCI(190) to mutagenic SmaI(403) and from mutagenic SmaI(403) to PvuII(826), respectively. To construct FLAG-tagged DETS-TEL cDNA, an internal fragment from mutagenic PstI(1040) to mutagenic HincII(1282) was deleted by digesting with the corresponding enzymes, blunting with T4 DNA polymerase, and religating. These mutated cDNAs were inserted into the EcoRI site of pME18S. FLAG-tagged DHLH-TEL cDNA was also cloned into the EcoR1 site of pCXN2 and pCAGIPuro. pME18S-EVI-l has been described previously (Tanaka et al., 1994) . The reporter plasmid, (EBS) 3 tkLuc, was generated by introducing double-stranded oligonucleotides containing three tandemly repeated EBS (5'-ATAAACAGGAAGTGG-3') (Bosselut et al., 1990) upstream of the tk promoter in tkLuc plasmid. (mEBS) 3 tkLuc plasmid was constructed by replacing two nucleotides in each EBS (5'-ATAAACACCAAGTGG-3') of (EBS) 3 tkLuc.
Isolation of MEL stable transfectants
To establish stable transfectants of wild-type-TEL or DHLH-TEL, 1 Â 10 7 MEL cells were electroporated with 20 mg of each cDNA cloned into pCXN2 plasmid that carries the neo R gene at 380 V and 975 mF using Gene Pulser (BIO-RAD). Transfected cells were selected with 0.8 mg/ml G418 (Sigma-Aldrich) and cloned by limiting dilution. The stable transfectants expressing wild-type-TEL were further electroporated with DHLH-TEL cDNA cloned into pCAGIPuro plasmid that carries the puromycin R gene. Double transfected cells were selected with 0.5 mg/ml puromycin (Sigma-Aldrich) and cloned by limiting dilution. Survival clones were screened for expression of wild-type-TEL and/or DHLH-TEL by Western analysis.
Immunoprecipitation and Western analysis
Nuclear extracts were prepared from MEL cells as reported previously (Tanaka et al., 1995) . COS7 cells were transfected with expression plasmids using the DEAE dextran method and lysed. Immunoprecipitation and Western analysis were performed as described previously (Maki et al., 1999) , using antimSin3A antibody (Novagen) for immunoprecipitation, and anti-FLAG (Sigma-Aldrich) or anti-FLI-1 (Santa Cruz Biotechnology) antibody for Western analysis. The blots were visualized by using the Problot AP system (Promega).
Northern analysis
Total RNA was isolated from cultured MEL cells using an RNeasy mini kit (QIAGEN). Northern analysis was carried out as described previously (Tanaka et al., 1995) . Rat ALAS-E and PCR-amplified mouse b-globin and b-actin cDNAs were used as probes.
RT-PCR analysis
RT-PCR was performed as described previously (Tanaka et al., 1995) 
EMSA
The procedures for EMSA were reported previously (Tanaka et al., 1995) . COS7 cells were transfected with wild-type-TEL or DHLH-TEL expression plasmid using the DEAE dextran method and lysed. The EBS oligonucleotide (oligonucleotide A), used as a probe or a specific competitor, has the sequence 5 0 -ATAAACAGGAAGTGG-3 0 , which was shown to bind various ETS proteins (Bosselut et al., 1990; Poirel et al., 1997) . The mutant oligonucleotide (oligonucleotide M), used as a nonspecific competitor, has the sequence 5 0 -ATAAACAC-CAAGTGG-3' . In competition studies, a 100-fold molar excess of unlabeled oligonucleotide was added with the probe. Anti-TEL antibody (Santa Cruz Biotechnology) was used for supershift analysis.
Luciferase assay
HeLa cells were transfected with 1 mg of the reporter plasmids, containing the Photinus luciferase gene (Promega), alone or along with 0.1-0.9 mg of the expression plasmids by the lipofectin method using Tfx-TM20 (Promega). Exponentially growing MEL cells were electroporated with 10 mg of the reporter plasmids alone or along with 7.5 or 15 mg of the expression plasmids at 380 V and 975 mF using Gene Pulser (BIO-RAD). To keep the transfection efficiency as constant as possible among the samples to be compared, the total amount of DNA in terms of weight was adjusted to be equal by adding the expression plasmid pME18S. Luciferase assays were performed as described previously (Maki et al., 1999) . A total of 20 ng of pRL-CMV plasmid (Promega) was cotransfected as an internal control of transfection efficiency, and the data were normalized to the Renilla luciferase activity. All transfection experiments were performed at least twice and similar results were obtained. 
